These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 22157175)
21. Testosterone use and shorter electrocardiographic QT interval duration in men living with and without HIV. Hiremath PG; Bhondoekhan F; Haberlen SA; Ashikaga H; Palella FJ; D'Souza G; Budoff MJ; Kingsley LA; Dobs AS; Post WS; Soliman EZ; Brown TT; Wu KC HIV Med; 2021 May; 22(5):418-421. PubMed ID: 33270338 [TBL] [Abstract][Full Text] [Related]
22. An evaluation strategy for potential QTc prolongation with chronic azithromycin therapy in cystic fibrosis. Lenehan PJ; Schramm CM; Collins MS J Cyst Fibros; 2016 Mar; 15(2):192-5. PubMed ID: 26698953 [TBL] [Abstract][Full Text] [Related]
23. Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event? Makaryus AN; Byrns K; Makaryus MN; Natarajan U; Singer C; Goldner B South Med J; 2006 Jan; 99(1):52-6. PubMed ID: 16466123 [TBL] [Abstract][Full Text] [Related]
24. Effects of Nemonoxacin on Thorough ECG QT/QTc Interval: A Randomized, Placebo- and Positive-controlled Crossover Study in Healthy Chinese Adults. Zhao C; Lv Y; Li X; Hou F; Ma X; Wei M; Kang Z; Cui L; Xia Y; Liu Y; Tian J Clin Ther; 2018 Jun; 40(6):983-992. PubMed ID: 29803534 [TBL] [Abstract][Full Text] [Related]
25. QTc Prolongation in COVID-19 Patients Using Chloroquine. Becker ML; Snijders D; van Gemeren CW; Kingma HJ; van Lelyveld SFL; Giezen TJ Cardiovasc Toxicol; 2021 Apr; 21(4):314-321. PubMed ID: 33387252 [TBL] [Abstract][Full Text] [Related]
26. Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study. van der Sijs H; Kowlesar R; Klootwijk AP; Nelwan SP; Vulto AG; van Gelder T Br J Clin Pharmacol; 2009 Mar; 67(3):347-54. PubMed ID: 19523015 [TBL] [Abstract][Full Text] [Related]
27. Prevalence and risk factors of prolonged QTc interval in HIV-infected patients: results of the HIV-HEART study. Reinsch N; Buhr C; Krings P; Kaelsch H; Neuhaus K; Wieneke H; Erbel R; Neumann T; HIV Clin Trials; 2009; 10(4):261-8. PubMed ID: 19723613 [TBL] [Abstract][Full Text] [Related]
28. QT interval prolongation and risk of life-threatening arrhythmias during toxoplasmosis prophylaxis with spiramycin in neonates. Stramba-Badiale M; Nador F; Porta N; Guffanti S; Frediani M; Colnaghi C; Grancini F; Motta G; Carnelli V; Schwartz PJ Am Heart J; 1997 Jan; 133(1):108-11. PubMed ID: 9006298 [TBL] [Abstract][Full Text] [Related]
29. [Effects of cisapride on QT interval in children]. Tamariz-Martel Moreno A; Baño Rodrigo A; Sánchez Bayle M; Montero Luis C; Acuña Quirós MD; Cano Fernández J Rev Esp Cardiol; 2004 Jan; 57(1):89-93. PubMed ID: 14746724 [TBL] [Abstract][Full Text] [Related]
30. Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies. Swaisland H; Plummer R; So K; Garnett S; Bannister W; Fabre MA; Dota C; Fielding A Cancer Chemother Pharmacol; 2016 Oct; 78(4):775-84. PubMed ID: 27553432 [TBL] [Abstract][Full Text] [Related]
31. QTc abnormalities in deliberate self-poisoning with moclobemide. Downes MA; Whyte IM; Isbister GK Intern Med J; 2005 Jul; 35(7):388-91. PubMed ID: 15958107 [TBL] [Abstract][Full Text] [Related]
32. QT interval prolongation and antiretroviral treatment: another point of interest. Chinello P; Petrosillo N Clin Infect Dis; 2007 May; 44(10):1388-9; author reply 1389-91. PubMed ID: 17443482 [No Abstract] [Full Text] [Related]
33. Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries. Sow PS; Otieno LF; Bissagnene E; Kityo C; Bennink R; Clevenbergh P; Wit FW; Waalberg E; Rinke de Wit TF; Lange JM; J Acquir Immune Defic Syndr; 2007 Mar; 44(3):262-7. PubMed ID: 17146376 [TBL] [Abstract][Full Text] [Related]
34. Predictors of electrocardiographic QT interval prolongation in men with HIV. Wu KC; Zhang L; Haberlen SA; Ashikaga H; Brown TT; Budoff MJ; D'Souza G; Kingsley LA; Palella FJ; Margolick JB; Martínez-Maza O; Soliman EZ; Post WS Heart; 2019 Apr; 105(7):559-565. PubMed ID: 30366934 [TBL] [Abstract][Full Text] [Related]
35. Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy. Mehta SA; Ahmed A; Laverty M; Holzman RS; Valentine F; Sivapalasingam S Clin Infect Dis; 2011 Sep; 53(5):490-6. PubMed ID: 21844033 [TBL] [Abstract][Full Text] [Related]
36. Beta-blocker decreases the increase in QT dispersion and transmural dispersion of repolarization induced by bepridil. Yoshiga Y; Shimizu A; Yamagata T; Hayano T; Ueyama T; Ohmura M; Itagaki K; Kimura M; Matsuzaki M Circ J; 2002 Nov; 66(11):1024-8. PubMed ID: 12419934 [TBL] [Abstract][Full Text] [Related]
37. [Metabolic syndrome and cardiovascular diseases in HIV patients]. Seybold U MMW Fortschr Med; 2012 May; 154 Suppl 1():30-1. PubMed ID: 22916595 [No Abstract] [Full Text] [Related]
38. Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya. Inzaule SC; Hamers RL; Mukui I; Were K; Owiti P; Kwaro D; Rinke de Wit TF; Zeh C AIDS; 2017 Jun; 31(10):1495-1498. PubMed ID: 28398959 [TBL] [Abstract][Full Text] [Related]
39. Vardenafil-associated QTc changes: not merely a normal autonomic process. Barbey JT Clin Pharmacol Ther; 2012 Apr; 91(4):580; author reply 580-1. PubMed ID: 22378160 [No Abstract] [Full Text] [Related]
40. Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts. Kesho Bora Study Group J Acquir Immune Defic Syndr; 2010 Aug; 54(5):533-41. PubMed ID: 20543706 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]